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1. introduction 
Diazepam is an effective anti-anxiety drug or mild 
tranquilizer [l] which is also used as a muscle relax- 
ant [2] , a presurgery medication [3], an anti-epileptic 
agent and in alcohol withdrawal. It is a widely pre- 
scribed drug [4]. The toxicity of diazepam is remark- 
ably low, as is its physical dependence [S] . Despite 
its widespread use, very little is known about the 
molecular basis of its action. 
Recent investigations, concerning macromolecules 
that bind hormones or drugs, have been carried out in 
an attempt to correlate such binding with pharmaco- 
logical actions. If a binding macromolecule is found 
for a drug, it is usually designated as a receptor, and 
it is assumed that an endogenous or naturally occur- 
ring ligand exists for the receptor. In the present study 
we found evidence for a highly specific, saturable 
binding of [3H]diazepam to a purified synaptosomal 
fraction from rat forebrain and present some of the 
characteristics of this binding. (A note of caution 
should be interjected since there is a great deal of 
difference between a binding entity, a receptor and a 
receptor site. In the past, glass, plastics, and other 
inert materials have been shown to be effective 
‘binders’ of ligands.) Such data should lead to a better 
understanding of the molecular action of diazepam. 
While this work was nearing completion, Squires and 
Braestrup [6] reported on benzodiazepine receptors 
in rat brain. In our report, using a higher specific 
activity of [3H]diazepam and a more purified binding 
fraction, we give amplified details of the diazepam- 
binding site. 
2. Materials and methods 
[mef/zvC3H] Diazepam was obtained from New 
England Nuclear Co., Boston, MA, and had a specific 
activity of 40 Ci/mmol. Pure unlabeled diazepam was 
a gift of Roche Laboratories, Nutley, NJ. The [3H]- 
diazepam was supplied in ethanol; subsequent dilutions 
were made in this solvent. In all experiments 1 fmol 
[methyZ-3H]diazepam was equal to 19 cpm, using 
standard liquid scintillation counting procedures. 
Neuraminidase (EC 3.2.1 .18), a-chymotrypsin (EC 
3.4.4.5) and phospholipase A (EC 3.1.1.4) were 
purchased from Sigma Chemical Co., St Louis, MO. 
Papain (EC 3.4.4.10) was obtained from National 
Biochemicals Corp., Cleveland, OH and required 
0.01 M EDTA for activation. Trypsin (EC 3.4.4.4) 
was obtained from Worthington Biochemical Corp., 
Freehold, NJ. All enzymes were crystalline and were 
used as weighed amounts in the assay. 
Routinely, brain sections of 150-200 g Sprague- 
Dawley or Holtzman rats were homogenized in 10 vol. 
0.32 M sucrose and the homogenate was centrifuged 
at 1000 X g for 10 min. Fractionation of the brain 
sections was as previously described [7-9] . The 
supernatant fluid was centrifuged at 10 000 X g for 
20 min to yield a ‘crude’ PZ synaptosomal pellet. To 
obtain a purer synaptosomal preparation, the com- 
bined P, pellets from 6 rat brains were resuspended 
in 60 ml 0.32 M sucrose and layered on a 1.20 M/ 
0.80 M/0.32 M discontinuous sucrose gradient and 
centrifuged at 53 500 X g for 2 h [7-91. This gradient 
system yields three fractions; A, B, and C. Fraction A 
consists primarily of microsomes, fraction B contained 
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predominantly synaptosomes with some microsomal 
contamination, and fraction C contains mainly mito- 
chondria [7-91. The fractions were removed and 
washed in 4 vol. 50 mM Tris buffer solution, pH 7 5, 
before use. 
To determine the optimal binding preparation, 
500 ~1 samples of the P, , A, B, and C fractions (resus- 
pended in 50 mM Tris buffer) along with crude homog- 
enates of the cerebellum, caudate nucleus, cerebral 
cortex, and whole forebrain (suspended in 0.32 M 
sucrose) were exposed to 5 nM [3H]diazepam or 
[3H]diazepam plus 3 PM unlabeled diazepam. The 
assay tubes were then incubated at 37’C for 15 min 
with shaking, followed by equilibration for 30 min in 
an ice bath. To collect the fraction binding the [3H]- 
diazepam, 10 ml of ice-cold 50 mM Tris buffer, pH 
7.5, was added to each incubation tube and the 
contents poured over Whatman GF/A glass fiber filters 
with suction. The filters were washed free of unbound 
diazepam with an additional 10 ml Tris buffer and 
placed in 5 ml Bray’s solution. j3H]Diazepam was 
measured in a Nuclear Chicago scintillation counter. 
Specifically-bound [3H]diazepam, as given herein, 
was the activity in the assay tube incubated with only 
the [3H]diazepam minus the activity in the appro- 
priate assay tube with the [3H]diazepam and the large 
excess of unlabeled diazepam, as is the convention in 
the determination of specific binding [ lo,1 l] . In most 
instances (except kinetic analyses) assays contained 
5 nM [3H] diazepam, since 16% of the available 
diazepam was bound at this concentration (lig.1); 
this allowed for greater or less binding to be measured 
in the various experiments, while still maintaining a 
600 molar excess in the nonspecific assay tubes. 
Because of its high binding activity (table 1) the 
B fraction was used for the kinetic studies. Aliquots, 
500 d, of the B fraction (4 mg protein/assay) were 
incubated with the [3H] diazepam (or [3H] diazepam 
plus unlabeled diazepam) at concentrations ranging 
from 0.01-500 nM. 
Enzyme studies involved a preincubation of the 
purified synaptosomal preparation with the enzymes. 
Various concentrations of trypsin, papain, a-chymo- 
trypsin, phospholipase A, and neuraminidase were 
incubated with the purified B fraction (4 mg protein/ 
assay) for 30 min at 37°C. After the preincubation, 
specifically-bound [3H] diazepam was determined as 
given above. 
Protein was determined by the method of Lowry 
et al. [12]. 
3. Results and discussion 
3 .l . Specific [ 3HJdia.zepam binding in various regions 
of the brain 
The data in table 1 show that homogenates of 
several areas of the rat brain specifically bind [3H]- 
diazepam; liver homogenates do not. Furthermore, 
boiling of the fractions abolished specific binding. Of 
the areas studied, the caudate nucleus and the cere- 
bellum bound the least [3H]diazepam, whereas the 
cerebral cortex and a P, homogenate of the forebrain 
bound greater amounts of the ligand. When the 
forebrain PZ fraction was subfractionated, a 4.5-fold 
increase (to 90.0 fmol [3H]diazepam bound/mg 
protein) in specific binding in the B (synaptosomal) 
fraction over the PZ fraction was found. This strongly 
suggests a forebrain nerve-ending localization for the 
[3H]diazepam. This purified synaptosomal fraction 
was used for all further studies. 
3.2. Kinetic studies 
Specific binding of [3H]diazepam was concentra- 
tion dependent and was saturable above lo* nM 
[3H]diazepam (fig.1). The larger variation in the 
Table 1 
Specific binding of 13H]diazepam in various rat brain 
sections and rat liver 
Section fmol/mg protein 
Cerebellum 10.0 
Caudate nucleus 8.5 
Cerebral cortex 20.7 
Total forebrain 
Crude homogenate 22.0 
Fraction P, 21.8 
Fraction A 4.1 
Fraction B 89.0 
Fraction C 9.0 
Liver 0 
Homogenates of the various sections were incubated with 
5 nM [“Hldiazepam as given in Materials and methods. 
Fractions A, B, C, and P, were isolated and incubated as 
described 
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Fig.1. Binding of [‘Hldiazepam to purified forebrain synaptosomal (nerve ending) macromolecules as a function of concentra- 
tion of [‘Hldiazepam. Each assay tube contained 4 mg purified synaptosomal protein and specific binding was determined as 
given in the text. Each point is the mean + 1 SE. 
middle portion of the log-linear curve may indicate 
that certain of the purified B fraction binding macro- 
molecules have bound lesser or greater amounts of 
‘endogenous ligand’; at high [‘Hldiazepam concentra- 
tions this variation would not be as evident, since the 
equilibrium would favor the [3H]diazepam concentra- 
tions. A Scatchard analysis (frg.2) demonstrated that 
each of the specific binding sites had the same intrinsic 
apparent binding constant of KdCappj 14.8 nM. (This 
is usually interpreted to mean one binding site per 
‘macromolecule’.) Furthermore, it was found (figs.1 
and 2) that maximal binding/4 mg synpatosomal 
protein was 1.45 pmol (or 363 fmol [3H]diazepam/ 
mg purified rat forebrain synaptosomal protein). By 
comparison, Squires and Braestrup [6] reported 
binding to membranes from 25 mg (wet wt) rat fore- 
brain as one binding site with affinity constant 
Kd 2.6 nM. 
3.3. Effect of ions 
The data in Table 2 are somewhat difficult to 
interpret. The fact that 10 mM EDTA lowered the 
binding by 20% may indicate an ionic requirement 
for optimal binding. The ions at the 10 mM concen- 
tration may be manifestations of the physicochemical 
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Fig.2. A Scatchard analysis of the data presented in fig.1. The 
fact that a straight line was obtained indicates that all of the 
binding sites have the same intrinsic binding constant (com- 
monly referred to as one binding site) with affinity, Kd(app) 
14.8 nM. Also, maximal binding occurs at 1.45 pmol/4 mg 
fraction B protein or 363 fmol [‘H]diazepam/mg purified 
forebrain nerve-ending protein. 
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Table 2 Table 3 
Effect of cations and EDTA on specific [sH]diazepam 
binding to purified rat synaptosome macromolecules 
The effects of various enzymes on specific [“Hldiazepam 
binding to purified rat forebrain synaptosomes 
Addition Specific binding 
(% control) 
Enzyme Final concentra- % Control binding 
tion &g/assay) 
Cation concentration 
None (control) 
Na’ 
K+ 
Li+ 
Ca* 
Mg* 
Mn” 
Pb” 
Cd” 
Hg2+ 
EDTA 
___- ____ 
10mM 100 PM 
100 100 
83 127 
74 129 
77 121 
93 105 
98 103 
157 95 
148 99 
188 103 
78 140 
79 100 
Trypsin 0.4 3.9 
0.08 85.7 
0.04 93.6 
Papain 2.0 70.3 
0.4 75.7 
cvChymotrypsin 10.0 3.2 
2.0 8.3 
1.0 7.1 
Phospholipase A 1.0 58.3 
0.2 79.9 
Experiments were carried out with 4 mg protein and 5 nM 
[3H]diazepam by the specific assay method described in the 
text except that cations or EDTA were added, as indicated. 
Cation concentrations are final concentrations. All cations 
were present as the chloride 
Neuraminidase 200.0 13.8 
40.0 52.4 
20.0 59.6 
Aliquots (500 ~1) of Fraction B were incubated with various 
concentrations of the enzymes (see text). All incubations 
were carried out with 5 nM [“Hldiazepam, using the assay 
system described in Materials and methods. Numbers are 
given as percentages of the npnenzyme-treated B fraction 
binding 
properties of the binding interactions but probably 
have little pharmacologic or physiologic significance. 
At 100 PM, Na+, K’ and Li’ all significantly raised 
the [3H]diazepam binding. This may be important 
since Na’ and K’ play a major role in maintaining 
membrane potentials, and Li’ is known to have 
psychotrophic activity. At 100 PM, HgV also stimu- 
lated binding; the reason for this stimulation is not 
known. 
complex, involving protein, phospholipid and 
N-acetylneuraminic acid. 
In summary, we have shown that diazepam binds 
specifically and tightly to purified rat forebrain synap- 
tosomes and probably acts through a receptor. Further- 
more, we have shown that the binding site is complex, 
probably involving protein, lipid and carbohydrate. 
3.4. Effects of prior enzyme treatment 
At high concentrations, cr-chymotrypsin essentially 
obliterated the binding of the [3H]diazepam to the 
purified synaptosomes (table 3). Similarly, high con- 
centrations of trypsin and papain also reduced the 
binding (table 3). These data implicate a protein 
involved at the binding site. Similarly, the work 
with the phospholipase tends to implicate the con- 
jugation of phospholipid at the site. Surprisingly, the 
treatment with neuraminidase suggests the presence 
of a sialic acid residue at the binding site (table 3). 
These data indicate that the binding site may be 
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